GlobeNewsWire
20 Jul 2026, 18:42 UTC · 12h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
A securities class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (REGN) regarding the period between August 1, 2025, and May 15, 2026. — Class action lawsuits regarding misleading financial statements create legal uncertainty and potential liability for the company.
-0.30The lawsuit alleges that Regeneron made materially false and misleading statements concerning its business operations, growth prospects, and financial stability. — Claims of artificially inflated stock prices due to misrepresentations can damage investor confidence in management's guidance.
-0.20Which stocks this story touches
The company is mentioned as being subject to a lawsuit via a call for affected shareholders to contact legal counsel.
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is mentioned as being subject to a lawsuit via a call for affected shareholders to contact legal counsel.
The company is facing a securities class action lawsuit alleging materially false and misleading statements that led to investor losses.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
10h ago
